Mr Andy Wing Leung KWOK

Business and Financial Advisor

Andy is an executive director of Asia Coal Limited (835:HK) (formerly known as Nubrands Group Holdings Limited) and was appointed as board chairman and CEO previously. Andy has more than 15 years of experience in finance and senior management. He holds a MBA from Tsinghua University, China and a degree in economics from the University of Sydney. He is a member of HKICPA and CPA Australia. He is also the sole director and beneficial owner of Billion Pacific Ventures Limited, the majority shareholder of Asia Coal Ltd (835:HK).


Dr. Kwok Yau Yan, MBBS (HK), FRCS (EDIN), FHKAM (Orthopaedic Surgery)

Clinical Advisor

Dr. Kwok is a consultant at the Department of Orthopaedics and Traumatology, University of Hong Kong-Shenzhen Hospital. Dr Kwok is also affiliated to Hong Kong Santorium & Hospital and Hong Kong Adventist Hospital. Dr Kwok graduated from the Faculty of Medicine at The University of Hong Kong in 1963 and became a fellow of Royal College of Surgeons of Edinburgh, FRCS (EDIN) in 1969. Later on, he obtained fellowship from Hong Kong Academy of Medicine in Orthopaedic Surgery in 1994.

Professor Raymond WY SUN

Scientific Advisor

Professor Sun obtained his PhD degree in the University of Hong Kong in 2004 and is currently working at the Department of Chemistry and Research Institute for Biomedical and Advanced Materials in Shantou University (P. R. China).  He is an expert in the design of novel metal-based supramolecular polymers and bio-friendly metal-organic frameworks (BioMOFs) to facilitate the transport of bioactive substances. Professor Sun published more than 45 international journals and held more than 9 international patents.


Dr. Victor YL LEUNG

Scientific Advisor

Dr. Leung obtained his PhD in Molecular and Developmental Genetics from the University of Hong Kong in 2003. After graduation, he received trainings under the mentorship of Prof Koichi Masuda and Professor Rocky Tuan, specializing in musculoskeletal regeneration and bioengineering. Since 2011, he has been appointed as the Director of the Intervertebral Disc Biology & Regenerative Engineering Program and has been a member of the Stem Cell and Regenerative Medicine Consortium and Centre for Reproduction, Development and Growth of the institute. He also served in the committee of the Orthopedic Research Society (ORS).